Sarah Duerinckx

Sarah Duerinckx

Auto-generated profile, based on publicly available information

Sarah Duerinckx

Child Neurology Department, Hôpital Universitaire de Bruxelles, member of European Reference Network EpiCARE, Hôpital Erasme Université Libre de Bruxelles Brussels Belgium

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2018 in Seminars in Cell & Developmental Biology
Verified
Journal Article
Closed access
SDSarah Duerinckx
Sarah Duerinckx
MAMarc Abramowicz
Marc Abramowicz

1 November 2024 in Science
Verified
Journal Article
Closed access
FKFlorian Kraft
Florian Kraft
PRPiere Rodriguez-Aliaga
Piere Rodriguez-Aliaga
WYWeimin Yuan
Weimin Yuan
LFLena Franken
Lena Franken
KZKamil Zajt
Kamil Zajt
IKIngo Kurth
Ingo Kurth
Malformations of the brain are common and vary in severity, from negligible to potentially fatal. Their causes have not been fully elucidated. Here, we report pathogenic variants in the core protein-folding machinery TRiC/CCT in individuals with brain malformations, intellectual disability, and seizures. The chaperonin TRiC is an obligate hetero-oligomer, and we identify variants in seven of its eight subunits, all of which impair function or assembly through different mechanisms. Transcriptome and proteome analyses of patient-derived fibroblasts demonstrate the various consequences of TRiC impairment. The results reveal an unexpected and potentially widespread role for protein folding in the development of the central nervous system and define a disease spectrum of “TRiCopathies.”

7 November 2019 in Human Mutation
Verified
Journal Article
Open access
PDF file
SDSarah Duerinckx
Sarah Duerinckx
VJValérie Jacquemin
Valérie Jacquemin
SDSéverine Drunat
Séverine Drunat
YVYoann Vial
Yoann Vial
SPSandrine Passemard
Sandrine Passemard
MAMarc Abramowicz
Marc Abramowicz
Primary Microcephaly (PM) is characterized by a small head since birth and is vastly heterogeneous both genetically and phenotypically. While most cases are monogenic, genetic interactions between Aspm and Wdr62 have recently been described in a mouse model of PM. Here, we used two complementary, holistic in vivo approaches: high throughput DNA sequencing of multiple PM genes in human PM patients, and genome‐edited zebrafish modeling for digenic inheritance of PM. Exomes of PM patients showed a significant burden of variants in 75 PM genes, that persisted after removing monogenic causes of PM (e.g., biallelic pathogenic variants in CEP152). This observation was replicated in an independent cohort of PM patients, where a PM gene panel showed in addition that the burden was carried by six centrosomal genes. Allelic frequencies were consistent with digenic inheritance. In zebrafish, non‐centrosomal gene casc5 ‐/‐ produced a severe PM phenotype, that was not modified by centrosomal genes aspm or wdr62 invalidation. A digenic, quadriallelic PM phenotype was produced by aspm and wdr62. Our observations provide strong evidence for digenic inheritance of human PM, involving centrosomal genes. Absence of genetic interaction between casc5 and aspm or wdr62 further delineates centrosomal and non‐centrosomal pathways in PM.

17 August 2021 in Molecular Genetics & Genomic Medicine
Verified
Journal Article
Open access
PDF file
SDSarah Duerinckx
Sarah Duerinckx
JDJulie Désir
Julie Désir
CPCamille Perazzolo
Camille Perazzolo
CBCindy Badoer
Cindy Badoer
VJValérie Jacquemin
Valérie Jacquemin
MAMarc Abramowicz
Marc Abramowicz
Background: Primary microcephaly (PM) is defined as a significant reduction in occipitofrontal circumference (OFC) of prenatal onset. Clinical and genetic heterogeneity of PM represents a diagnostic challenge.Methods: We performed detailed phenotypic and genomic analyses in a large cohort (n = 169) of patients referred for PM and could establish a molecular diagnosis in 38 patients.Results: Pathogenic variants in ASPM and WDR62 were the most frequent causes in non‐consanguineous patients in our cohort. In consanguineous patients, microarray and targeted gene panel analyses reached a diagnostic yield of 67%, which contrasts with a much lower rate in non‐consanguineous patients (9%). Our series includes 11 novel pathogenic variants and we identify novel candidate genes including IGF2BP3 and DNAH2. We confirm the progression of microcephaly over time in affected children. Epilepsy was an important associated feature in our PM cohort, affecting 34% of patients with a molecular confirmation of the PM diagnosis, with various degrees of severity and seizure types.Conclusion: Our findings will help to prioritize genomic investigations, accelerate molecular diagnoses, and improve the management of PM patients.

4 September 2021 in Molecular Genetics & Genomic Medicine
Verified
Journal Article
Open access
PDF file
ASAsma Sassi
Asma Sassi
JDJulie Désir
Julie Désir
SDSarah Duerinckx
Sarah Duerinckx
JSJulie Soblet
Julie Soblet
SDSonia Van Dooren
Sonia Van Dooren
ADAnne Delbaere
Anne Delbaere
Background: Premature ovarian insufficiency (POI) is a heterogeneous clinical syndrome defined by a premature loss of ovarian function that associates menstrual disturbances and hypergonatropic hypogonadism. POI is a major cause of female infertility affecting 1% of women before the age of 40 and up to 0.01% before the age of 20. The etiology of POI may be iatrogenic, auto‐immune or genetic but remains however undetermined in a large majority of cases. An underlying genetic etiology has to be searched in idiopathic cases, particularly in the context of a family history of POI.Methods: Whole exome sequencing (WES) was performed in trio in a Belgian patient presenting POI and in her two parents. The patient presented delayed puberty and primary amenorrhea with hypergonadotropic hypogonadism.Results: WES identified two novel compound heterozygous truncating mutations in the Newborn oogenesis homeobox (NOBOX) gene, c.826C>T (p.(Arg276Ter)) and c.1421del (p.(Gly474AlafsTer76)). Both mutations were confirmed by Sanger sequencing in the proband's sister who presented the same phenotype. Both variants were pathogenic and very likely responsible for the severe POI in this family.Conclusion: We report here for the first time compound heterozygous truncating mutations of NOBOX in outbred patients, generalizing biallelic NOBOX null mutations as a cause of severe POI with primary amenorrhea. In addition, our findings also suggest that NOBOX haploinsufficiency is tolerated.

24 April 2018 in Molecular Genetics & Genomic Medicine
Verified
Journal Article
Open access
PDF file
SDSarah Duerinckx
Sarah Duerinckx
MMMarije Meuwissen
Marije Meuwissen
CPCamille Perazzolo
Camille Perazzolo
LDLaurence Desmyter
Laurence Desmyter
IPIsabelle Pirson
Isabelle Pirson
MAMarc Abramowicz
Marc Abramowicz
Background: Autosomal recessive intellectual disability (ARID) is vastly heterogeneous. Truncating mutations of TRAPPC9 were reported in 8 ARID families. Autosomal recessive primary microcephaly (MCPH) represents another subgroup of ARID, itself very heterogeneous, where the size of the brain is very small since birth. MCPH1 plays a role at the centrosome via a BRCT1 domain, and in DNA Damage Repair (DDR) via BRCT2 and BRCT3, and it is not clear which of these two mechanisms causes MCPH in man.Methods: We studied the phenotype and sequenced the exome in two siblings with MCPH and their unaffected sister.Results: Homozygous mutations of TRAPPC9 (p.Leu178Pro) and of MCPH1 (p.Arg741X) were found in both affected siblings. Brain MRI showed anomalies previously associated with TRAPPC9 defects, supporting the implication of TRAPPC9 in the phenotype. Importantly, the asymptomatic sister with normal head size was homozygous for the MCPH1 truncating mutation and heterozygous for the TRAPPC9 mutation.Conclusion: The affected siblings represent the first ARID cases with a TRAPPC9 missense mutation and with microcephaly of prenatal onset of. Furthermore, their unaffected sister represents strong evidence that the lack of MCPH1 BRCT3 domain does not cause MCPH in man, supporting a bifunctional model of MCPH1 where the centrosomal function is involved in brain volumic development and not the DDR function.